Ergoteles LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$74,082
-91.1%
114,131
-76.5%
0.00%
-89.7%
Q3 2022$835,000
-28.1%
485,434
-48.2%
0.03%
-17.1%
Q2 2022$1,162,000
+198.7%
936,900
+337.8%
0.04%
+150.0%
Q3 2021$389,000
+221.5%
214,000
+367.2%
0.01%
+366.7%
Q2 2021$121,000
+181.4%
45,800
+166.3%
0.00%
-50.0%
Q3 2020$43,00017,2000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders